arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Candel Therapeutics, Inc.

CADL

$10.58 0.00 (0.00%) at close

26 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Candel Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $659.8M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -9.3% ↗

FCF / Share $-0.30

Trailing P/E —

Price / Book 5.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$31.00K

— 0.0% —

Net Income Profit after all expenses

$-8.86M

↑ +70.0% —

FCF / Share Free cash flow per share

$-0.30

↓ -75.7% —

Long-Term Debt Long-term obligations

$4.22M

↓ -37.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution → Caution Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	0.0% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	-41.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	36.4% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	87.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-2.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-13.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-124.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	6.7% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-123.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	3.3% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	-135.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	N/M	56.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	90.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	-109.6% Weak ↓ Weak Declining Year-over-year change in net income	-5.9% Weak ↓ Weak Declining Year-over-year change in net income	78.4% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-26.8% Weak ↑ Weak Improving Year-over-year change in net income	-26.2% Weak ↑ Weak Improving Year-over-year change in net income	-131.3% Weak ↓ Weak Declining Year-over-year change in net income	6.5% Fair ↑ Fair Improving Year-over-year change in net income	-118.3% Weak ↑ Weak Improving Year-over-year change in net income	2.9% Caution ↑ Caution Improving Year-over-year change in net income	-131.7% Weak ↑ Weak Improving Year-over-year change in net income	-906.3% Weak ↓ Weak Declining Year-over-year change in net income	N/M	46.2% Excellent ↓ Excellent Declining Year-over-year change in net income	75.7% Excellent ↑ Excellent Improving Year-over-year change in net income	80.5% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-532.8% Weak Weak Year-over-year change in net income	-493.9% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	-75.7% Weak Weak Year-over-year change in free cash flow	—	—	—	41.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	23.7% Good Good Year-over-year change in free cash flow	—	—	—	—	—	-6.4% Weak Weak Year-over-year change in free cash flow	39.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	2.11x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.86x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.17x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.25x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	1.41x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.86x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	9.41x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-3.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.31x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-9.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	62.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	207.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-41.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-64.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	9.7% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	13.4% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	21.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	14.7% Good Good Return earned on debt + equity capital invested Optimal: > 10%	16.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-8.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-8.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-16.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-6.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-56.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-479%)	-14.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-5.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	9.9% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-34%)	-21.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	69.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+365%)	223.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1387%)	-137.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1017%)	-87.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-680%)	-36.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-344%)	-31.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-308%)	-22.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-248%)	-10.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-16.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-6.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-1.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-109%)	2.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-83%)	-25.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-271%)	39.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+164%)	16.3% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+9%)	44.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+196%)	17.2% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+15%)	23.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+55%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	-0.28x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-146%)	-0.67x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-212%)	1.53x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+156%)	—	0.62x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.54x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-10%)	0.48x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-20%)	—	—	—	—	—	—	—	—	-0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-103%)	—	—	—	—
Interest Coverage (x)	-10.41x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-82.03x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-47.36x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-26.57x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-20.87x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-17.98x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.12x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-12.23x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2.28x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.25x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.87x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-19.27x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14.02x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-17.11x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-20.12x Weak Weak Operating income divided by interest expense Optimal: > 5x	-76.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-194.83M	$-119.73M	$-86.96M	$-100.69M	$-92.17M	$-102.65M	$-12.33M	$-14.75M	$-16.54M	$-35.41M	$-28.64M	$-35.19M	$-40.23M	$-70.06M	—	—	$-94.32M	$-82.64M	—	—	—	$-34.57M	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	-0.49x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.80x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.20x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.66x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.79x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	-0.08x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	—	—	$0.00	$0.00	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.14	$-0.55	$-0.21	$-0.09	$0.15	$-0.39	$-0.33	$-0.74	$-0.28	$-0.38	$-0.29	$-0.33	$-0.30	$-0.17	$-0.30	$-0.14	—	$0.51	$-0.69	$-1.46	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.30	—	$-0.19	$-0.17	$-0.17	—	—	—	$-0.29	—	—	—	$-0.38	—	$-0.33	$-0.27	—	—	$-0.31	$-0.44	—	—	—	—	—	—
Book Value per Share (USD)	$1.88	$0.95	$1.46	$1.64	$1.52	$1.42	$-0.47	$-0.32	$0.20	$0.44	$0.80	$1.06	$1.37	$1.65	$1.80	$2.09	$2.22	$2.24	$2.70	$-3.68	—	$-2.03	—	—	—	—
Tangible Book Value per Share (USD)	$1.88	$0.95	$1.46	$1.64	$1.52	$1.42	$-0.47	$-0.32	$0.20	$0.44	$0.80	$1.06	$1.37	$1.65	$1.80	$2.09	$2.22	$2.24	$2.70	$-3.68	—	$-2.03	—	—	—	—
Basic Weighted Avg Shares (shares)	62.36M	—	54.89M	51.49M	50.48M	—	32.01M	29.88M	29.20M	—	28.92M	28.92M	28.92M	—	28.89M	28.81M	—	—	23.33M	11.72M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$190.70M	$112.39M	$79.20M	$88.89M	$73.08M	$66.28M	$2.82M	$8.74M	$13.60M	$22.61M	$34.77M	$45.20M	$56.64M	$66.33M	—	—	$90.17M	$79.58M	—	—	—	$30.43M	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	$4.22M	$6.71M	$9.17M	—	$14.34M	$16.70M	$19.02M	—	—	—	—	—	—	—	—	$483.00K	—	—	—	—
Total Equity (USD)	$138.03M	$51.92M	$80.12M	$90.21M	$74.67M	$66.33M	$-15.26M	$-9.97M	$5.98M	$12.74M	$23.02M	$30.77M	$39.65M	$47.71M	$52.13M	$60.07M	$63.76M	$64.14M	$62.99M	$-43.17M	$-27.50M	$-23.56M	$-14.82M	$-12.34M	$-10.07M	$-8.04M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	$31.00K	$31.00K	$31.00K	$31.00K	$31.00K	$31.00K	$31.00K	$31.00K	$31.00K	$31.00K	$31.00K	—	—
Depreciation Expense (USD)	$149.00K	$163.00K	$200.00K	$200.00K	$245.00K	$245.00K	$200.00K	$200.00K	$251.00K	$249.00K	$200.00K	$236.00K	$230.00K	$221.00K	—	$187.00K	$165.00K	$178.00K	$21.00K	$7.00K	$26.00K	$6.00K	$45.00K	—	—	—
Net Income, GAAP (USD)	$-8.86M	$-29.50M	$-11.27M	$-4.80M	$7.38M	$-14.07M	$-10.65M	$-22.24M	$-8.22M	$-11.10M	$-8.44M	$-9.61M	$-8.79M	$-5.08M	$-8.69M	$-4.15M	$-874.00K	$1.60M	$-16.16M	$-17.08M	$-4.48M	$-10.48M	$-2.55M	$-2.88M	—	—
Operating Cash Flow (USD)	$-18.04M	$-10.57M	$-10.24M	$-8.89M	$-8.62M	$-5.81M	—	—	$-8.44M	$-7.42M	—	—	$-10.82M	$-6.88M	$-9.38M	$-7.10M	$-8.05M	$-5.24M	$-6.89M	$-4.46M	$-5.63M	$-3.42M	$-1.50M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Candel Therapeutics, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CADL with peers